ADMA Biologics, Inc. (ADMA)
Company Info
Highlights
$5.08B
$0.81
26.31
$344.58M
$180.30M
$123.41M
$6.10 - $23.64
$25.74
5.62%
3.58
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ADMA Biologics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ADMA Biologics, Inc. had a return of 24.26% year-to-date (YTD) and 252.81% in the last 12 months. Over the past 10 years, ADMA Biologics, Inc. had an annualized return of 8.98%, while the S&P 500 had an annualized return of 9.68%, indicating that ADMA Biologics, Inc. did not perform as well as the benchmark.
ADMA
24.26%
13.90%
32.20%
252.81%
51.42%
8.98%
^GSPC (Benchmark)
-10.18%
-5.91%
-9.57%
5.19%
12.98%
9.68%
Monthly Returns
The table below presents the monthly returns of ADMA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -5.83% | 1.49% | 21.05% | 7.41% | 24.26% | ||||||||
| 2024 | 14.82% | 3.28% | 23.13% | -1.21% | 46.47% | 17.07% | 9.84% | 40.96% | 15.48% | -18.41% | 23.30% | -14.72% | 279.42% |
| 2023 | -4.90% | -3.79% | -6.76% | 1.21% | 21.49% | -9.34% | 12.47% | -7.23% | -7.01% | -5.59% | 9.47% | 22.16% | 16.49% |
| 2022 | 2.84% | 11.03% | 13.66% | 0.55% | 11.41% | -3.41% | 8.08% | 26.17% | -10.00% | 16.05% | 18.44% | 16.17% | 175.18% |
| 2021 | 13.85% | 4.05% | -23.81% | 11.36% | -10.71% | -8.57% | -3.13% | -13.55% | -15.67% | 14.16% | 6.98% | 2.17% | -27.69% |
| 2020 | -1.00% | -26.39% | -1.20% | 2.43% | 11.53% | -10.94% | 21.84% | -28.57% | -6.27% | -16.74% | 2.51% | -4.41% | -51.25% |
| 2019 | 23.43% | 38.64% | -7.33% | 22.16% | -10.37% | -6.75% | -6.46% | 23.76% | -0.67% | 9.89% | -2.86% | -15.79% | 67.36% |
| 2018 | 15.89% | 0.81% | 22.67% | 8.04% | 9.05% | -16.79% | 44.57% | -1.99% | -2.82% | -13.53% | -1.86% | -54.65% | -25.55% |
| 2017 | -0.20% | -8.61% | 4.50% | -7.58% | -17.96% | 0.00% | -6.76% | 0.00% | -10.72% | -24.03% | 23.93% | 10.69% | -37.30% |
| 2016 | -25.22% | -21.29% | 70.32% | -15.45% | 13.30% | -23.23% | 31.93% | -27.26% | 26.80% | -22.93% | -0.72% | -7.58% | -36.56% |
| 2015 | -3.31% | -11.67% | 2.73% | -14.18% | 1.78% | 8.18% | 0.65% | -0.97% | -9.43% | 9.81% | -0.00% | -12.09% | -27.75% |
| 2014 | 10.26% | -1.05% | -1.88% | -7.19% | 12.90% | 11.43% | 1.54% | -5.56% | 10.16% | 14.08% | 5.28% | -9.70% | 43.21% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 98, ADMA is among the top 2% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the ADMA Biologics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ADMA Biologics, Inc. was 91.28%, occurring on Oct 11, 2021. Recovery took 691 trading sessions.
The current ADMA Biologics, Inc. drawdown is 5.79%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -91.28% | Nov 7, 2014 | 1741 | Oct 11, 2021 | 691 | Jul 12, 2024 | 2432 |
| -31.74% | Nov 11, 2024 | 71 | Feb 25, 2025 | — | — | — |
| -24.61% | Oct 9, 2024 | 9 | Oct 21, 2024 | 14 | Nov 8, 2024 | 23 |
| -20.47% | Oct 18, 2013 | 46 | Dec 23, 2013 | 17 | Jan 27, 2014 | 63 |
| -18.89% | Mar 4, 2014 | 40 | May 12, 2014 | 12 | Jun 3, 2014 | 52 |
Volatility
Volatility Chart
The current ADMA Biologics, Inc. volatility is 19.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an overview of how ADMA Biologics, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
PEG Ratio
PS Ratio
PB Ratio
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ADMA Biologics, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |